Videos
New Targets for Acute Myeloid Leukemia
Eunice Wang, MD, Chief of Leukemia Service at Roswell Park Comprehensive Cancer Center, discusses the emergence of new therapeutic options for the treatment of Acute Myeloid Leukemia.
Checkmate 744: Subgroup Analyses of an International Trial for Relapsed Pediatric Hodgkin Lymphoma
Kara Kelly, MD, Chair of the Department of Pediatric Oncology at Roswell Park Comprehensive Cancer Center, presents a subgroup analyses of an international trial for relapsed pediatric Hodgkin Lymphoma.
New Imaging Guidelines for Monoclonal Plasma Cell Disorders
Jens Hillengass, MD, Chief of Myeloma at Roswell Park Comprehensive Cancer Center, reviews new imaging guidelines for multiple myeloma, as well as other monoclonal plasma cell disorders, that were published in The Lancet Oncology.
CAR T-cell and Transplant: Cellular Therapies for Malignant Disease
Philip McCarthy, MD, Director of the Transplant and Cellular Therapy Center at Roswell Park Comprehensive Cancer Center, provides an overview of the utilization of T-Cell therapies for malignant diseases, with an emphasis on immune effector therapy.
Elizabeth Griffiths, MD, Director of MDS at Roswell Park Comprehensive Cancer Center, discusses what MDS is, describes the mutational profiling in normal aging, as well as in MDS, and instructs on how to distinguish mutations from the disease.
Transplant Eligibilty for Myeloma Patients
Jens Hillengass, MD, gives a presentation on myeloma treatments and the types of patients who are transplant eligible and those who are non-transplant eligible.